NCT05379582

Brief Summary

In critical ill patients, feeding protocol is one of the important factor which determines the successful implementation of enteral nutrition(EN). Acute gastrointestinal injury(AGI) affects feeding tolerance, which greatly determines the successful implementation of feeding protocol. In our previously study, we found that transabdominal intestinal sonography is helpful to diagnosis AGI. Thus in this study ,we apply transabdominal gastrointestinal sonography to feeding protocol, to assess the feasibility of gastrointestinal sonography assisted enteral nutrition and its impact on critical ill patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
294

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 28, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

May 18, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
Last Updated

January 28, 2026

Status Verified

January 1, 2026

Enrollment Period

1.3 years

First QC Date

April 28, 2022

Last Update Submit

January 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Target-reaching rate through enteral route

    percentage of participants who reach target calorie through enteral route

    Within first week

Secondary Outcomes (13)

  • The incidence of feeding intolerance

    Within first week

  • The application of parenteral nutrition

    Within first week

  • The application of prokinetic drugs

    Within first week

  • The ues of vasoactive drugs

    Within first week

  • Mechanical ventilation

    Within first week

  • +8 more secondary outcomes

Study Arms (2)

control group

NO INTERVENTION

Implement nutrition therapy according to existing feeding procedures

intervention group

EXPERIMENTAL

Implement nutrition therapy according a procedure assisted by gastrointestinal ultrasound

Other: Implement nutrition therapy according a procedure assisted by gastrointestinal ultrasound

Interventions

Once the critical ill patients is stable, enteral nutrition was initiated following a procedure assisted by gastrointestinal ultrasound.

intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The age is not less than 18 years
  • within 24 hours after entering ICU
  • Acute Physiology and Chronic Health Evaluation II (APACHE II) score \> 8
  • the estimated length of stay in ICU is more than 3 days
  • informed consent

You may not qualify if:

  • The normal anatomy of stomach, small intestine or the right colon was significantly changed (Gastrectomy, esophagectomy, pancreaticoduodenectomy, gastrointestinal bypass surgery, the presence of short bowel syndrome,etc.)
  • Uncontrolled gastrointestinal bleeding
  • Uncontrolled intestinal obstruction
  • Uncontrolled mesenteric vascular disease
  • Pregnancy
  • breastfeeding
  • Received enteral nutrition or parenteral nutrition within 24 hours prior to ICU admission
  • Predict death within 48 hours after ICU admission
  • Enrolled in this study before.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nanjing Drum Tower Hospital

Nanjing, Jiangsu, 210000, China

Location

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • WenKui Yu, Professor

    The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2022

First Posted

May 18, 2022

Study Start

July 1, 2022

Primary Completion

October 1, 2023

Study Completion

October 1, 2023

Last Updated

January 28, 2026

Record last verified: 2026-01

Locations